🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/12/2018 | 0,5248 USD |
| 14/09/2018 | 0,4580 USD |
| 14/06/2018 | 0,4580 USD |
| 14/03/2018 | 0,4580 USD |
| 14/12/2017 | 0,4580 USD |
| 14/09/2017 | 0,4485 USD |
| 13/06/2017 | 0,4485 USD |
| 13/03/2017 | 0,4485 USD |
| 13/12/2016 | 0,4485 USD |
| 13/09/2016 | 0,4389 USD |
| 13/06/2016 | 0,4389 USD |
| 11/03/2016 | 0,4389 USD |
| 11/12/2015 | 0,4389 USD |
| 11/09/2015 | 0,4294 USD |
| 11/06/2015 | 0,4294 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/02/1985 | 2,56 | 2,58 | 2,55 | 2,57 | +0,00% | 1,03% | 8.368.070 |
| 11/02/1985 | 2,57 | 2,57 | 2,55 | 2,57 | +1,17% | 0,64% | 5.059.325 |
| 08/02/1985 | 2,54 | 2,55 | 2,52 | 2,54 | -0,26% | 1,43% | 7.232.458 |
| 07/02/1985 | 2,56 | 2,56 | 2,54 | 2,55 | -0,39% | 1,04% | 5.346.058 |
| 06/02/1985 | 2,56 | 2,57 | 2,55 | 2,56 | -0,26% | 0,78% | 7.836.106 |
| 05/02/1985 | 2,58 | 2,59 | 2,56 | 2,56 | -0,52% | 1,16% | 8.477.482 |
| 04/02/1985 | 2,53 | 2,58 | 2,52 | 2,58 | +1,83% | 2,23% | 9.443.318 |
| 01/02/1985 | 2,53 | 2,54 | 2,52 | 2,53 | -0,52% | 0,92% | 3.429.475 |
| 31/01/1985 | 2,52 | 2,54 | 2,52 | 2,54 | +0,65% | 1,05% | 6.266.621 |
| 30/01/1985 | 2,53 | 2,54 | 2,51 | 2,53 | +1,33% | 0,92% | 12.163.507 |
| 29/01/1985 | 2,48 | 2,50 | 2,46 | 2,49 | +0,80% | 1,74% | 6.866.496 |
| 28/01/1985 | 2,47 | 2,48 | 2,45 | 2,48 | -0,13% | 1,34% | 14.102.726 |
| 25/01/1985 | 2,45 | 2,48 | 2,45 | 2,48 | +1,08% | 1,35% | 7.364.506 |
| 24/01/1985 | 2,50 | 2,53 | 2,45 | 2,45 | -1,72% | 3,31% | 9.481.046 |
| 23/01/1985 | 2,50 | 2,50 | 2,46 | 2,49 | -0,13% | 1,72% | 9.624.413 |
| 22/01/1985 | 2,54 | 2,55 | 2,48 | 2,50 | -1,57% | 2,61% | 15.868.397 |
| 21/01/1985 | 2,48 | 2,55 | 2,48 | 2,54 | +2,40% | 2,94% | 14.891.242 |
| 18/01/1985 | 2,48 | 2,49 | 2,46 | 2,48 | +0,27% | 1,20% | 4.595.270 |
| 17/01/1985 | 2,47 | 2,48 | 2,46 | 2,47 | -0,14% | 0,81% | 2.939.011 |
| 16/01/1985 | 2,48 | 2,50 | 2,46 | 2,48 | -0,27% | 1,60% | 7.036.272 |
| 15/01/1985 | 2,50 | 2,51 | 2,48 | 2,48 | -1,19% | 1,45% | 6.726.902 |
| 14/01/1985 | 2,45 | 2,52 | 2,45 | 2,51 | +2,16% | 2,97% | 7.805.923 |
| 11/01/1985 | 2,47 | 2,48 | 2,45 | 2,46 | -0,80% | 1,07% | 3.652.070 |
| 10/01/1985 | 2,43 | 2,48 | 2,43 | 2,48 | +2,05% | 2,04% | 5.115.917 |
| 09/01/1985 | 2,41 | 2,44 | 2,40 | 2,43 | +1,25% | 1,51% | 4.380.221 |
| 08/01/1985 | 2,40 | 2,41 | 2,39 | 2,40 | +0,14% | 0,69% | 3.708.662 |
| 07/01/1985 | 2,40 | 2,41 | 2,39 | 2,40 | -0,42% | 0,83% | 6.575.990 |
| 04/01/1985 | 2,42 | 2,42 | 2,40 | 2,41 | -0,82% | 0,96% | 4.233.082 |
| 03/01/1985 | 2,46 | 2,47 | 2,43 | 2,43 | -1,74% | 1,61% | 15.747.667 |
| 02/01/1985 | 2,49 | 2,49 | 2,47 | 2,47 | -0,93% | 0,93% | 5.187.600 |